platinum resistant ovarian cancer
Showing 1 - 4 of 4
Platinum Resistant Ovarian Cancer, Non Small Cell Lung Cancer Metastatic Trial in Worldwide (upifitamab rilsodotin)
Recruiting
- Platinum Resistant Ovarian Cancer
- Non Small Cell Lung Cancer Metastatic
- upifitamab rilsodotin
-
Birmingham, Alabama
- +171 more
Jan 23, 2023
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Platinum Resistant Ovarian Cancer Trial in Boston (Paclitaxel)
Completed
- Platinum Resistant Ovarian Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Apr 23, 2020
Platinum Resistant Ovarian Cancer Trial in Belgium, Germany, United States (Fosbretabulin tromethamine, Placebo)
Terminated
- Platinum Resistant Ovarian Cancer
- Fosbretabulin tromethamine
- Placebo
-
Birmingham, Alabama
- +39 more
Mar 20, 2018